Sigilon Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 4.62, indicating more challenging environment then in the first quarter 2023, but still, it is a far cry from any concerns. Sigilon Therapeutics Inc 's Accounts Receivable average collection period in the Jun 30 2023 quarter, has increased to 79 days, from 53 days, in the Mar 31 2023 quarter.

If we take a look into Healthcare sector 448 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. 3018.

What is Receivable Turnover Ratio?
What is Sigilon Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SGTX Receivables Turnover Ratio	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter
Y / Y Receivable Change	29717.39 %	7900 %	5761.02 %	-14.81 %	-87.08 %
Y / Y Revenue Change	104.65 %	53.49 %	32.86 %	118.39 %	6.62 %
Receivable Turnover Ratio (TTM)	4.62	6.92	14.52	294.37	233.57
SGTX's Total Ranking	# 3018	# 3018	# 3012	# 2996	# 3027
Accounts Receivable average collection period days	79	53	25	1	2
Seq. Receivable Change	38.27 %	43.44 %	14934.78 %	0 %	-62.9 %
Seq. Revenue Change	21.45 %	83.74 %	-37.82 %	47.49 %	-8.91 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 151
Healthcare Sector	# 449
Overall Market	# 3018

Receivable Turnover Ratio Statistics
High	Average	Low
0.22	0.12	0.06
(Jun 30 2023)		(Dec 31 2021)

SGTX Company Profile • Back to SGTX Efficiency Comparisons • Compare SGTX Receivables Turnover Ratio to its Competitors

Financial Statements
Sigilon Therapeutics Inc 's Accounts Receivable	$ 7 Millions	Visit SGTX's Balance sheet
Sigilon Therapeutics Inc 's Sales TTM	$ 18 Millions	Visit SGTX's Income Statement
Sources of SGTX's Revenues		Visit SGTX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SGTX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SGTX's Growth Rates	SGTX's Roa	SGTX's Inventory Turnover Ratio	SGTX's Dividend Comparisons
SGTX's Profitability Ratios	SGTX's Roi	SGTX's Asset Turnover Ratio	SGTX's Dividend Growth
SGTX's Valuation Ratios	SGTX's Roe	SGTX's Financial Strength Ratios	SGTX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2023	Receivable at quarter ending Jun 30 2023
Teleflex Incorporated	7.07	$ 2,898.539 Millions	$ 409.854 Millions
Uphealth Inc	7.06	$ 155.855 Millions	$ 22.068 Millions
Evolus Inc	7.04	$ 168.612 Millions	$ 23.955 Millions
Puma Biotechnology Inc	7.04	$ 230.120 Millions	$ 32.709 Millions
Yunhong Green Cti Ltd	7.03	$ 16.398 Millions	$ 2.333 Millions
G1 Therapeutics Inc	7.02	$ 89.164 Millions	$ 12.703 Millions
3m Company	7.02	$ 33,054.000 Millions	$ 4,709.750 Millions
Minerva Surgical Inc	6.99	$ 51.327 Millions	$ 7.343 Millions
Kyntra Bio Inc	6.98	$ 130.581 Millions	$ 18.720 Millions
Pacira Biosciences inc	6.97	$ 669.229 Millions	$ 96.038 Millions
Elutia Inc	6.96	$ 48.084 Millions	$ 6.910 Millions
Lakeland Industries Inc	6.96	$ 119.155 Millions	$ 17.127 Millions
Pediatrix Medical Group Inc	6.94	$ 1,995.344 Millions	$ 287.614 Millions
The Oncology Institute Inc	6.93	$ 292.817 Millions	$ 42.272 Millions
Tenet Healthcare Corp	6.88	$ 19,894.000 Millions	$ 2,892.500 Millions
Harvard Bioscience Inc	6.87	$ 113.997 Millions	$ 16.592 Millions
Universal Health Services Inc	6.85	$ 13,798.663 Millions	$ 2,013.964 Millions
Vaso Corporation	6.83	$ 83.164 Millions	$ 12.171 Millions
Fulcrum Therapeutics Inc	6.81	$ 3.043 Millions	$ 0.447 Millions
Select Medical Holdings Corp	6.81	$ 6,488.758 Millions	$ 953.074 Millions
Axogen inc	6.77	$ 147.942 Millions	$ 21.850 Millions
Infusystem Holdings Inc	6.74	$ 118.214 Millions	$ 17.530 Millions
Merit Medical Systems Inc	6.73	$ 1,198.211 Millions	$ 178.172 Millions
Biomerica Inc	6.71	$ 5.339 Millions	$ 0.796 Millions
Quanterix Corporation	6.71	$ 109.832 Millions	$ 16.377 Millions
Enhabit Inc	6.71	$ 1,056.200 Millions	$ 157.500 Millions
Zoetis Inc	6.70	$ 8,222.000 Millions	$ 1,228.000 Millions
Astrotech Corp	6.67	$ 0.750 Millions	$ 0.112 Millions
Nuwellis Inc	6.67	$ 8.305 Millions	$ 1.246 Millions
Boston Scientific Corporation	6.66	$ 13,402.000 Millions	$ 2,012.750 Millions

Date modified: 2026-09-08T15:11:00+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.